Cell therapy weekly: allogeneic CAR-T therapy demonstrates positive results for B-cell malignancies

This week: positive top-line results have been announced for CTX110, an allogeneic CAR-T therapy targeting B-cell malignancies; a Japanese research team has described how they have performed the world’s first iPSC visual cell transplant in a patient with pigmentary retinal degeneration; the US FDA has granted RMAT and ODD to an investigational allogeneic cell therapy; and a closed cell processing system has been launched for cell therapy development and manufacturing. The news highlights: Allogeneic CAR-T therapy demonstrates positive results for B-cell malignancies iPSC visual cell transplant performed successfully in patient with pigmentary retinal degeneration Closed cell processing system launched for...